Tafamidis

From Proteopedia

Jump to: navigation, search

Tafamidis

Drag the structure with the mouse to rotate

References

  1. "Vyndaqel- tafamidis meglumine capsule, liquid filled Vyndamax- tafamidis capsule, liquid filled". DailyMed. 30 August 2019. Retrieved 24 November 2019
  2. "Vyndaqel EPAR". European Medicines Agency. 16 October 2019. Retrieved 24 November 2019.
  3. "FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis". U.S. Food and Drug Administration. 14 September 2019. Archived from the original on 14 September 2019.
  4. Said G, Grippon S, Kirkpatrick P. Tafamidis. Nat Rev Drug Discov. 2012 Mar 1;11(3):185-6. PMID:22378262 doi:10.1038/nrd3675
  5. "Vyndaqel 20 mg soft capsules - Summary of Product Characteristics". Electronic Medicines Compendium. Retrieved 2 April 2018

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Personal tools